Billing and Reimbursement

Billing and Reimbursement

Billing Support

ClearNote Health is committed to providing our health care services to all patients. If you are uninsured or lack coverage for services, you are encouraged to contact the ClearNote Health Reimbursement Team to review possible financial assistance options.

Patient Assistance Program

ClearNote Health welcomes all insurance plans. Your level of coverage varies by plan type. We offer financial assistance to qualifying patients who are uninsured or underinsured. To learn more about eligibility, please reach out to the ClearNote Health Customer Success Team.

Please reach out to our Customer Success team at  +1 833-258-7827 if you have any questions.

 

Important information

The Avantect Pancreatic Cancer Test is an early detection test. The test does not establish a diagnosis of pancreatic cancer, and results should be considered in the context of other clinical criteria. Definitive diagnosis of pancreatic cancer usually requires a series of imaging scans, blood tests, and a biopsy. Not all pancreatic cancers will be detected. Some patients with pancreatic cancer may have a “Signal not detected” result. Some patients without pancreatic cancer may have a “Signal detected” result. False-negative and false-positive results are possible. A “Signal not detected” result does not guarantee that no pancreatic cancer is present. In some cases, no result is obtained. While this is very uncommon, it may be caused by shipping delays or when there is not enough cell-free DNA for the test in the patient’s blood. If this happens, we generally ask for a repeat blood sample for testing at no extra cost.

The test was developed in the ClearNote Health CLIA-certified (CLIA# 05D2249973) and CAP-accredited (CAP# 9219174) laboratory and has not been cleared or approved by the US Food and Drug Administration (FDA).

References and notes

  1. ClearNote Health, data on file.